Heart Disease Clinical Trials in Philadelphia

Showing 241-260 of 263 trials

Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure

NCT00419965

The primary objective of this study is to determine the utility of GRK2 to differentiate between normal patients and patient groups that differ by the presence/absence of HF symptoms, systolic or diastolic left ventricular dysfunction, and risk factors; and to evaluate if a new assay provides similar values as traditional methods for measuring GRK2 levels.

Heart Failure

Thomas Jefferson University582 participantsStarted Oct 2006

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

NCT00351559

This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.

Graft RejectionHeart Diseases

XDx629 participantsStarted Jan 2005

Palo Alto, California, United States • Stanford, California, United States • Chicago, Illinois, United States +10 more locations

UNKNOWNPHASE1< 1 mile

Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant

NCT00364598

The purpose of this study is to obtain human heart tissue after treatment with Anginera to determine its effect on a variety of things that might indicate improvement in heart function. Patients who will have a left ventricular assist device (LVAD) implanted while they wait for a donated heart will be treated with Anginera. At the time of heart transplant, their diseased heart which is removed will be analyzed by microscopic examination to see what effect Anginera had.

Heart Failure

Theregen, Inc.15 participantsStarted Dec 2006

New Haven, Connecticut, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant

Heart Disease Trials in Other Cities

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Lipid Lowering in Patients With Statin Intolerance

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Attain StarFix™ Model 4195 Left Ventricular Lead

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

DILIPO (DILutIonal HyPOnatremia)

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Biomarkers in Acute Heart Failure

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Other Conditions in Philadelphia